Hyperprolactinemia in patients on antipsychotic drugs causes ADP-stimulated platelet activation that might explain the increased risk for venous thromboembolism: pilot study.
about
Antipsychotics and risk of venous thromboembolism: A population-based case-control studyProlactin levels, endothelial dysfunction, and the risk of cardiovascular events and mortality in patients with CKD.Assessment of serum prolactin levels in acute myocardial infarction: The role of pharmacotherapyPulmonary embolism related to amisulpride treatment: a case reportAssessment of risk of venous thromboembolism and its possible prevention in psychiatric patients.Risk of venous thromboembolism due to antipsychotic drug therapy.Venous thromboembolism in recipients of antipsychotics: incidence, mechanisms and management.Risk of venous thromboembolism during treatment with antipsychotic agents.Drug-induced thrombosis: an update.Risperidone and pulmonary embolism: a harmful association? Case series and review of the literature.Antipsychotic drugs and risk of idiopathic venous thromboembolism: a nested case-control study using the CPRD.Platelet haemostatic function in psychiatric disorders: Effects of antidepressants and antipsychotic drugs.The first- and second-generation antipsychotic drugs affect ADP-induced platelet aggregation.Risk of thromboembolic events in patients with prolactinomas compared with patients with nonfunctional pituitary adenomas.Venous Thromboembolism During Treatment with Antipsychotics: A Review of Current Evidence.Effects of prolactin on platelet activation and blood clotting.
P2860
Q34143987-7E195C2D-E888-48AF-A085-AD904C83829EQ35758553-C6D7793F-2297-4EE4-A50F-280C3B9E4BD9Q36550324-F93465B3-6862-4F93-B253-76C6D3BD4194Q36692244-6AF74D48-9452-4A43-9586-DCF65E7F2B00Q37090397-87445CA0-F310-474D-9912-389E41F61E84Q37537576-E81D49D1-004E-44A7-83C3-F04B8A1E36F3Q38021516-5AC27FCA-C212-4E4E-901D-DDEC923F3A8CQ38068538-2BD03E8E-FF64-468C-9818-5087054D930FQ38103820-F0777AEC-E0EE-420B-93D4-15D7CCB93406Q38257153-CFF9D1C3-E1FC-42BC-BEBE-DF02E445373AQ38418927-6F6059D3-40AD-402B-BE87-A4BF6E9A50BEQ38816985-4E44769F-9397-424A-B34C-92B369AB511BQ43135408-9CD79C11-4477-4970-8B3C-F7AE47536CC0Q45203173-AD449D8F-0FEE-4EE5-B230-DF34EF977C40Q50103957-4B97B3B9-E47A-48A9-9F79-3F954BC43BFDQ51252028-1DFBD761-8085-4B75-A6C2-D2BEA4834AC2
P2860
Hyperprolactinemia in patients on antipsychotic drugs causes ADP-stimulated platelet activation that might explain the increased risk for venous thromboembolism: pilot study.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Hyperprolactinemia in patients ...... thromboembolism: pilot study.
@en
Hyperprolactinemia in patients ...... thromboembolism: pilot study.
@nl
type
label
Hyperprolactinemia in patients ...... thromboembolism: pilot study.
@en
Hyperprolactinemia in patients ...... thromboembolism: pilot study.
@nl
prefLabel
Hyperprolactinemia in patients ...... thromboembolism: pilot study.
@en
Hyperprolactinemia in patients ...... thromboembolism: pilot study.
@nl
P2093
P1476
Hyperprolactinemia in patients ...... thromboembolism: pilot study.
@en
P2093
Betina Hentschel
Henri Wallaschofski
Herman J Gertz
Manfred Donné
Markus Kiefer
Martin Eigenthaler
Tobias Lohmann
P304
P356
10.1097/01.JCP.0000088914.24613.51
P407
P577
2003-10-01T00:00:00Z